Boron tribromide → 5,6-Dimethyl-4-(1-methyl-1,2,3,4-tetrahydroisoquinolin-2-yl)-2-(4-fluoro-2-hydroxyphenylamino) pyrimidine
Reaction equation
B(Br)(Br)Br.[CH3:5][C:6]1[C:7]([N:23]2[CH2:32][CH2:31][C:30]3[C:25](=[CH:26][CH:27]=[CH:28][CH:29]=3)[CH:24]2[CH3:33])=[N:8][C:9]([NH:13][C:14]2[CH:19]=[CH:18][C:17]([F:20])=[CH:16][C:15]=2[O:21]C)=[N:10][C:11]=1[CH3:12]>ClCCl>[CH3:5][C:6]1[C:7]([N:23]2[CH2:32][CH2:31][C:30]3[C:25](=[CH:26][CH:27]=[CH:28][CH:29]=3)[CH:24]2[CH3:33])=[N:8][C:9]([NH:13][C:14]2[CH:19]=[CH:18][C:17]([F:20])=[CH:16][C:15]=2[OH:21])=[N:10][C:11]=1[CH3:12]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
Boron tribromide (1M dichloromethane solution, 1.9 ml, 1.9 mmol) was added dropwise to a solution of 5,6-dimethyl-4-(1-methyl-1,2,3,4-tetrahydroisoquinolin-2-yl)-2-(4-fluoro-2-methoxyphenylamino)pyrimidine(0.247 g, 0.63 mmol) in dichloromethane(2 ml) at 0° C., stirred for 1 hour, and poured into ice water. The separated organic layer was concentrated and the residual oil was purified by column chromatography (dichloromethane/methanol=10/1) to give 57 mg of the titled compound. (Yield 24%) NMR (CDCl3): 1.5 (d, 3H), 2.2 (s, 3H), 2.3 (s, 3H), 2.7 (m, 1H), 3.1 (m, 1H), 3.5 (m, 1H), 3.9 (m, 1H), 5.0 (q, 1H), 6.6 (m, 6H), 7.0 (d, 1H).
Workup
- concentrationThe separated organic layer was concentrated
- customthe residual oil was purified by column chromatography (dichloromethane/methanol=10/1)
Sources & evidence
- ORD record
- ord-8b46a10dd9c64c438de909c565bf315c
- Source dataset
- uspto-grants-2002_03
- Patent number
- US06352993B1
Reaction notes
Loading…